About 834 results for "bayer healthcare"

Bayer Animal Health Marks 50 Years in Shawnee

Bayer HealthCare LLC today celebrated the 50th anniversary of its Animal Health Division's presence in Shawnee, Kan., and its parent company's 150th anniversary. More than 450 employees, community and political leaders and industry partners ... Veterinary Practice News, 17 hours ago

Bayer HealthCare Animal Health Marks its 50th Anniversary in Shawnee, Kansas - NewsBlaze, 23 hours ago

Bayer HealthCare Animal Health Back as American Royal Sponsor - The Farmer, 2 weeks ago

More from: Asian Hospital & Healthcare Management, Sys-Con Canada...and 18 other sources

[x]

79 images for bayer healthcare
Bio Spectrum Asia, 1 week ago	Bio Spectrum Asia, 1 month ago	Trading-House, 1 week ago	KXXV-TV, 20 hours ago	92.9 WLMI, 4 weeks ago
Reuters India, 4 weeks ago	Hospital Pharmacy Europe, 2 weeks ago	New Ross Standard, 1 month ago	Daily Finance, 1 month ago	RTTNews.com, 1 month ago

79 images for bayer healthcare

left

right

Bayer progresses on APAC hepatocellular carcinoma trial

Bio Spectrum Asia, 1 week ago

Bayer plans on new hires for St. Joseph plant

SHAWNEE, Kan. -- Company officials announced Tuesday plans by Bayer HealthCare to add an undetermined number of new jobs to its animal health manufacturing plant in St. Joseph. The hiring plans are still being developed and there are no firm ...

Individual.com, 19 hours ago Bayer AG Plans on New Hires for St. Joseph Plant BioSpace, 6 hours ago

MassDevice

Bayer HealthCare announces positive results from Phase III mCNV study

Bayer HealthCare, a health care products subsidiary of Bayer AG, has announced positive results for VEGF Trap-Eye from the Phase III MYRROR study in myopic choroidal neovascularization, or mCNV. In this trial, patients receiving VEGF Trap-Eye at a ...

Individual.com, 1 day ago BAYER AG: Bayer HealthCare supports diabetes projects in the Middle East, North Africa and Europe 4 Traders, 1 week ago Regeneron and Bayer Report Positive Phase 3 Results for EYLEA (aflibercept) Injection in Myopic Choroidal Neovascularization (mCNV) Drugs.com, 1 week ago Diabetes Care: -- Bayer HealthCare supports diabetes projects in the Middle East, North Africa and Europe -- "Excellence across Borders" program fosters practical solutions in diabetes management to propel therapy outcome Individual.com, 1 week ago

More from: Investors Business Daily, StockHouse USA...and 41 other sources

[x]

Bio Spectrum Asia

Bayer and Onyx report positive data from Phase III thyroid cancer trial

Bayer HealthCare Pharmaceuticals, a research-based pharmaceutical company, and Onyx Pharmaceuticals, Inc., a biopharmaceutical company, have reported positive data from the Phase III DECISION trial investigating the use of sorafenib tablets in ...

Individual.com, 1 week ago Bayer progresses on APAC hepatocellular carcinoma trial Bio Spectrum Asia, 1 week ago Positive Data on Bayer/REGN's Eye Drug Zacks Yahoo! Finance, 1 week ago Bayer announces positive data from Phase III PAH study Individual.com, 2 weeks ago

More from: BioSpace, Pharmacy Choice...and 28 other sources

[x]

Bayer HealthCare Launches First-Ever Alka-Seltzer® Rocket Contest to Engage Students in STEM Education

BusinessWeek, 1 week ago Bayer HealthCare (BAY) Launches First-Ever Alka-Seltzer® Rocket Contest to Engage Students in STEM Education BioSpace, 1 week ago

More from: TMC Net, EON: Enhanced Online News...and 8 other sources

[x]

Bayer HealthCare receives EU approval for acute coronary syndrome drug

Bayer HealthCare has received approval novel oral anticoagulant Xarelto from the European Commission for the prevention of atherothrombotic events after an Acute Coronary Syndrome, or ACS, in adult patients with elevated cardiac biomarkers at a dose ...

Individual.com, 2 weeks ago Bayer HealthCare receives FDA approval for prostate cancer drug Individual.com, 2 weeks ago Findings from Bayer Healthcare Provide New Insights into Epithelial Cells NewsRX, 2 weeks ago European Commission approves Bayer's Xarelto for secondary prevention after acute coronary syndrome PharmaBiz, 3 weeks ago

More from: , NewsRX...and 1 other sources, NewsRX...and 1 other sources

[x]

Actavis Confirms Generic Safyral® Patent Challenge

Merck & CIE, Bayer Pharma AG and Bayer Healthcare Pharmaceuticals Inc. filed suit against Actavis on June 4, 2013 Based on available information, Actavis believes it may be a "first applicant" to file an ANDA for the generic version of Safyral® ...

Stockhouse Canada, 2 weeks ago Actavis (ACT) Affirms Generic Challenge to Bayer's Safyral Street Insider, 2 weeks ago Actavis files ANDA for oral contraceptive drug Individual.com, 1 day ago Actavis (ACT) says it's filed an Abbreviated New Drug Application with the FDA seeking approval to market Drospirenone/Ethinyl Estradiol/Levomefolate Calcium Tablets And Levomefolate Calcium Tablets, a generic version of Bayer's ([[BAYRY.PK) Safyral, wh Seeking Alpha, 2 weeks ago

More from: PharmaBiz, Individual.com...and 19 other sources

[x]

Positive Data on Bayer/Onyx's Nexavar

The HealthCare segment of Bayer (BAYRY) and partner, Onyx Pharmaceuticals Inc. (ONXX) recently announced positive results from the phase III DECISION study on Nexavar (sorafenib) tablets in patients suffering from locally advanced or metastatic ...

Yahoo! Finance, 2 weeks ago

More from: , Individual.com...and 3 other sources, Individual.com...and 3 other sources

[x]

NICE Says Yes to Eylea(R) in Draft Final Guidance - The First Newly Approved wAMD Therapy Since 2007

/PRNewswire/ -- Bayer HealthCare's new treatment,Eylea(R),to prevent vision loss caused by wet age-related macular degeneration (wAMD) could ease pressure on NHS eye clinics as the number of patients with wAMD continues to rise The National ...

Individual.com, 2 weeks ago NICE says yes to Eylea® Hospital Pharmacy Europe, 2 weeks ago Lucentis rival one step away from NHS approval Pharma Times, 2 weeks ago NICE Says Yes to Eylea® in Draft Final Guidance - The First Newly Approved wAMD Therapy Since 2007 Asian Hospital & Healthcare Management, 2 weeks ago

More from: , Sys-Con Australia...and 1 other sources

[x]

Bayer seeks regulatory approval for hypertension drug in Japan

Bayer HealthCare has filed the oral investigational drug riociguat for the treatment of chronic thromboembolic pulmonary hypertension, or CTEPH, for regulatory approval in Japan. "To date, there is no pharmacological treatment available for CTEPH.